Inventor · Glenmoore, PA, US

Eliot Ohlstein

18Patents
9h-index
9Co-inventors
65Inventor score

Filing activity: Dec 29, 1987 → Oct 22, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US5393772A Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation Human Necessities 62 Expired
US5308862A Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation Human Necessities 58 Expired
US5453436A Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanolamine compounds Human Necessities 49 Expired
US5643939A Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation Human Necessities 21 Expired
US9956194B2 Compositions and methods of using modified release solabegron for lower urinary tract symptoms Human Necessities 14 Active
US8642661B2 Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists Human Necessities 12 Active
US9522129B2 Pharmaceutical Combination Human Necessities 12 Active
US9907767B2 Pharmaceutical compositions and the treatment of overactive bladder Human Necessities 9 Active
US9487493B2 Use of a PPAR-delta agonist for treating muscle atrophy Chemistry; Metallurgy 9 Active
US9968613B2 Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Chemistry; Metallurgy 8 Active
US10456406B2 Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Chemistry; Metallurgy 6 Active
US10350182B2 Pharmaceutical compositions and the treatment of overactive bladder Human Necessities 4 Active
US11096946B2 Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Chemistry; Metallurgy 1 Active
US4882348A 2-(aminoalkylthio)imidazoles as dopamine-.beta.-hydroxylase inhibitors Human Necessities 1 Expired
US4935438A Dopamine-.beta.-hydroxylase inhibitors Human Necessities 1 Expired
US10751311B2 Compositions and methods of using modified release solabegron for lower urinary tract symptoms Human Necessities 0 Active
US10668034B2 Pharmaceutical compositions and the treatment of overactive bladder Human Necessities 0 Active
US4912226A Intermediate to dopamine-.beta.-hydroxylase inhibitors Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.